Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

CTX

Crescita Therapeutics (CTX)

Crescita Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:TSX:CTX
FechaHoraFuenteTítuloSímboloCompañía
01/06/202304:00PR Newswire (Canada)Croma-Pharma: Launch of topical anaesthetic Pliaglis® in EuropeTSX:CTXCrescita Therapeutics Inc
21/01/202106:30PR Newswire (US)Crescita Announces Filing of New Medical Device LicenseTSX:CTXCrescita Therapeutics Inc
26/11/202006:30PR Newswire (Canada)Crescita Therapeutics Announces Approval of Normal Course Issuer BidTSX:CTXCrescita Therapeutics Inc
12/11/202006:30PR Newswire (Canada)Crescita Reports Third Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
05/11/202006:30PR Newswire (Canada)Crescita Announces Licensing Agreement for Pliaglis® in ChinaTSX:CTXCrescita Therapeutics Inc
12/08/202006:30PR Newswire (US)Crescita Reports Second Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
28/07/202006:30PR Newswire (US)Crescita to Receive One-time Cash Payment Following Amendment to Pliaglis® U.S. Licensing AgreementTSX:CTXCrescita Therapeutics Inc
27/05/202006:30PR Newswire (US)Crescita Reports First Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
14/05/202007:30PR Newswire (US)Crescita Therapeutics Announces the Results of its Annual General Meeting of ShareholdersTSX:CTXCrescita Therapeutics Inc
28/04/202016:58PR Newswire (US)Crescita Therapeutics Announces Extension of First Quarter 2020 Filings Due to COVID-19TSX:CTXCrescita Therapeutics Inc
24/03/202018:23PR Newswire (US)Crescita Therapeutics Announces Measures in Response to COVID-19 VirusTSX:CTXCrescita Therapeutics Inc
18/03/202006:30PR Newswire (US)Crescita Reports Q4 and Fiscal 2019 ResultsTSX:CTXCrescita Therapeutics Inc
10/03/202008:30PR Newswire (Canada)Pliaglis® finally available in CanadaTSX:CTXCrescita Therapeutics Inc
10/03/202008:30PR Newswire (Canada)Pliaglis® enfin disponible au CanadaTSX:CTXCrescita Therapeutics Inc
11/02/202006:30PR Newswire (US)Crescita Announces Positive Topline Results from Two Pivotal Phase 3 Clinical Studies for its Lead Pipeline Product in Patien...TSX:CTXCrescita Therapeutics Inc
24/01/202006:30PR Newswire (US)Crescita Awarded Cannabis Research License from Health CanadaTSX:CTXCrescita Therapeutics Inc
22/01/202006:30PR Newswire (US)Crescita Secures Line of Credit with the Royal Bank of Canada Following Repayment in Full of Knight Therapeutics LoanTSX:CTXCrescita Therapeutics Inc
20/01/202006:30PR Newswire (US)Crescita Signs Exclusive Distribution Agreement with FILLMEDTSX:CTXCrescita Therapeutics Inc
07/11/201906:30PR Newswire (US)Crescita Reports 2019 Third Quarter ResultsTSX:CTXCrescita Therapeutics Inc
05/11/201917:26PR Newswire (US)U.S. Food and Drug Administration Approves Enhanced Formulation of Pliaglis®TSX:CTXCrescita Therapeutics Inc
28/10/201906:30PR Newswire (US)Sundial and Crescita Sign Exclusive Partnership to Develop Cannabis and Hemp TopicalsTSX:CTXCrescita Therapeutics Inc
05/09/201906:00PR Newswire (Canada)Crescita Therapeutics Inc. to Present at the Fall Investor Summit on September 16th-17th in New York CityTSX:CTXCrescita Therapeutics Inc
08/08/201906:30PR Newswire (US)Crescita Reports Profitable 2019 Second Quarter ResultsTSX:CTXCrescita Therapeutics Inc
16/07/201906:30PR Newswire (Canada)United States Patent and Trademark Office Issues U.S. Patent Covering an Enhanced Formulation of Pliaglis®TSX:CTXCrescita Therapeutics Inc
11/07/201906:30PR Newswire (US)Crescita Therapeutics to Host Investor Webcast on July 24, 2019TSX:CTXCrescita Therapeutics Inc
04/07/201906:30PR Newswire (Canada)Crescita Therapeutics Inc. Receives 2nd Instalment of Up-Front Payment of €1.25 Million Following First Commercial Sale of ...TSX:CTXCrescita Therapeutics Inc
17/06/201919:17PR Newswire (US)Crescita Therapeutics Inc. Announces Intention to Make Normal Course Issuer BidTSX:CTXCrescita Therapeutics Inc
30/05/201907:00PR Newswire (US)Crescita to Present at the 9th Annual LD Micro Invitational in Los Angeles, CaliforniaTSX:CTXCrescita Therapeutics Inc
29/05/201907:00PR Newswire (US)Crescita Therapeutics Engages Bristol Capital to Provide Investor Relations and Communications ServicesTSX:CTXCrescita Therapeutics Inc
15/05/201907:31PR Newswire (US)Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of ShareholdersTSX:CTXCrescita Therapeutics Inc
 Showing the most relevant articles for your search:TSX:CTX

Su Consulta Reciente

Delayed Upgrade Clock